Covid-19 Vaccine Suppliers & Bulk Manufacturers
Available Forms: Vial for reconstitution (injectable, intramuscular)
Available Strengths: 30 µg per dose
Reference Brands: Comirnaty
Category:
Nanoemulsion/Nanoparticles
Comirnaty (Pfizer-BioNTech COVID-19 vaccine) uses mRNA technology to instruct cells to produce spike proteins, triggering an immune response. It provides strong protection against COVID-19, reduces severe illness, and supports herd immunity. Benefits include rapid immune activation and high efficacy in preventing infection and complications.
COVID-19 Vaccine is available in Vial for reconstitution (injectable, intramuscular)
and strengths such as 30 µg per dose.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, COVID-19 Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
COVID-19 Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Comirnaty (Pfizer-BioNTech COVID-19 vaccine) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. FDA approval involved extensive clinical validation, safety monitoring, and efficacy data, while in the EU, CE marking certifies conformity with MDR standards. Both regions require validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial results, and quality management systems. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective COVID-19 vaccines supporting global health efforts and pandemic control.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing